Article Text


Cardiovascular Therapeutics.
  1. D J COLTART, Consultant Cardiologist/Clinical Director
  1. Cardiothoracic Unit, St Thomas' Hospital
  2. London, UK

    Statistics from

    Cardiovascular Therapeutics. By R Haiat, G Leroy. (Pp 346; £29.95.) Manson Publishing Ltd, 1999. ISBN 1-874545-002-8.***

    Cardiovascular therapeutics over the past 10 years has produced multiple trials in every area of cardiology. The results of these trials have not only fundamentally changed the practice of cardiology but has resulted in the greatest reduction in mortality perhaps seen in the annals of clinical medicine. It is extremely difficult for any one individual to keep abreast of all these trials and therefore this particular book highlighting the main points of the major clinical trials is essential reading to all those involved in everyday clinical practice. The authors, senior cardiologists and directors of their respective departments with Professor Haiat the current President of the French Society of Cardiology, are eminently suitable from their great authority to analyse the major recent clinical trials. They therefore have covered the fields of hypertension, stable and unstable angina, myocardial infarction, lipid abnormalities, chronic heart failure, atrial fibrillation, and venous thromboembolism and heart valve prosthesis.

    In a succinct way they have drawn together the differences and common aspects of major clinical trials highlighting the most important aspects and the unresolved issues still outstanding in clinical medicine. They emphasise what may be deemed to be best medical practice. Needless to say this book will become dated as more trials are published and I note this book only is as recent as the trials published until 31 December 1998. Therefore some of the major trials presented in 1999 are not analysed in the microscopic way these authors have digested the various trials.

    This is an extremely easy book to read, presented in a very systematic fashion, and I can warmly recommend it to all those involved in clinical cardiology. This book therefore helps the clinician to confirm what he already knew but also it confirms those aspects which need to be examined in the future. Not only will clinical cardiologists gain greater insight into their practice from this book but the pharmaceutical industry in general should use this as a guideline to their future thoughts on trials.

    View Abstract

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.